Use of medicine composition containing Milkvetch Root

A kind of composition and medicine technology, applied in the field of medicine

Inactive Publication Date: 2006-03-15
TIANJIN TASLY PHARMA CO LTD
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the research on this pharmaceutical composition mainly focuses on the research on coronary heart disease and angina pectoris, and there is no rep

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Get Astragalus 86.5g (65.6%), Salvia miltiorrhiza 21.3g (16.1%), Radix Notoginseng 3.5g (2.7%), Dalbergia 20.6g (15.6%), auxiliary material polyethylene glycol-6000 30g; Panax notoginseng, decoct twice, add 7 times the amount of water each time, 2 hours each time, combine the decoction liquid, filter, concentrate the filtrate to 900ml, add 95% ethanol to make the alcohol concentration reach 70%, let it stand for 12 ~24 hours, filter, recover ethanol, concentrate into extract with relative density of 1.32~1.38 (50~60°C);

[0066] Add water to decoct the crushed Astragalus membranaceus twice, add 6 times the amount of water each time, extract for 2 hours and 1 hour in turn, combine the filtrate, and when it is concentrated to about 1500ml, add 95% ethanol to make the alcohol concentration 60%, let it stand After 12-24 hours, filter, recover ethanol from the filtrate, concentrate to about 400ml, add 95% ethanol to make the alcohol concentration 80%, let it stand for 12-24 ...

Embodiment 2

[0068] Get Radix Astragali 40.6g (30.0%), Salvia Miltiorrhiza 44.8g (33.1%), Panax notoginseng 11.2g (8.3%), Radix Dalbergia 38.6g (28.6%), make traditional Chinese medicine preparation of the present invention by conventional tablet preparation method.

Embodiment 3

[0070] Take 77.3g (57.1%) of Radix Astragali, 22.8g (16.8%) of Salvia Miltiorrhiza, 4.8g (3.6%) of Radix Notoginseng, 30.5g (22.5%) of Dalbergia, and 28g of polyethylene glycol-6000 as an auxiliary material. The preparation technology of embodiment 1 is made Chinese medicine preparation of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A Chinese medicine with high antioxidizing activity for radically treating coronary heart disease and angina pectoris is prepared from astragalus root, red sage root, notoginseng and dalbergia wood.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of a pharmaceutical composition in the preparation of antioxidant drugs. Background technique [0002] Coronary heart disease and angina pectoris are common diseases in our country. Oxidative stress and hypertension are important causes of coronary artery damage, leading to coronary heart disease, angina pectoris and even myocardial infarction. The clinical manifestations of coronary heart disease and angina pectoris belong to the category of "chest pain" and "true pain" in modern medicine. Traditional Chinese medicine believes that there are several pathogenesis, some of which are "pain due to deficiency of heart and evil dryness"; Some are "painful due to evil weeping in the collaterals"; some are "painful due to blood deficiency, and some are painful due to phlegm dampness"; According to this characteristic, someone has develope...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/53A61K9/00A61P9/10A61P39/06
Inventor 李永强郑永锋
Owner TIANJIN TASLY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products